Evidence map›Paper›PMID 28512685›Full record

ArticleJournal of neurovirology2017

Modeling brain lentiviral infections during antiretroviral therapy in AIDS.

Weston C Roda, Michael Y Li, Michael S Akinwumi, Eugene L Asahchop, Benjamin B Gelman, Kenneth W Witwer, Christopher Power

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurovirology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Modeling HIV-1 infection in the brain.PLoS computational biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Weston C RodaDepartment of Mathematical and Statistical Sciences, University of Alberta, Edmonton, AB, T6G 2G1, Canada.
Michael Y LiDepartment of Mathematical and Statistical Sciences, University of Alberta, Edmonton, AB, T6G 2G1, Canada. mli@math.ualberta.ca.
Michael S AkinwumiDepartment of Mathematical and Statistical Sciences, University of Alberta, Edmonton, AB, T6G 2G1, Canada.
Eugene L AsahchopDivision of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada.
Benjamin B GelmanTexas NeuroAIDS Research Center and Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
Kenneth W WitwerDepartment of Molecular and Comparative Pathobiology and Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Christopher PowerDivision of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada.
University of Alberta · CAJohns Hopkins Medicine · USThe University of Texas Medical Branch at Galveston · US

Funding

Texas NeuroAIDS Research CenterU24MH100930 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GELMAN, BENJAMIN B. · 2013 to 2023
$12.1M
NIMH NIH HHS U24 MH100930
6 · The paper itself

Abstract

Understanding HIV-1 replication and latency in different reservoirs is an ongoing challenge in the care of patients with HIV/AIDS. A mathematical model was created to describe and predict the viral dynamics of HIV-1 and SIV infection within the brain during effective combination antiretroviral therapy (cART). The mathematical model was formulated based on the biology of lentiviral infection of brain macrophages and used to describe the dynamics of transmission and progression of lentiviral infection in brain. Based on previous reports quantifying total viral DNA levels in brain from HIV-1 and SIV infections, estimates of integrated proviral DNA burden were made, which were used to calibrate the mathematical model predicting viral accrual in brain macrophages from primary infection. The annual rate at which susceptible brain macrophages become HIV-1 infected was estimated to be 2.90×10

Indexed as

Models, StatisticalAnimalsAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveBrainDisease EradicationHIV-1HIV InfectionsHumansMacaca mulattaSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusViral LoadAnti-HIV AgentsBrain macrophageCombination antiretroviral therapy (cART)HIV-1Mathematical modelSIVViral dynamics

Identifiers

PMID28512685
OpenAlexW2615014527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.